Can a New York resident get peptides by telehealth?
Public Health Law Article 29-G (sections 2999-cc and following) limits telehealth to telemedicine, store-and-forward technology, remote patient monitoring, and audio-only telephone communication. It defines telemedicine as synchronous two-way audio-visual communication, and store-and-forward as the asynchronous transmission of patient-specific digital images or pre-recorded videos from a provider at an originating site to a telehealth provider at a distant site. It also says telehealth does not include electronic messaging alone. Article 29-G governs telehealth delivery and Medicaid reimbursement; it is not a prescribing standard. Providers must hold a New York license and are held to the professional standards of Education Law Title VIII. None of the peptides in this database are controlled substances. This record leaves asynchronous prescribing unresolved because the New York law read for this record is silent: no statute, regulation, or board statement that was found says whether an asynchronous evaluation can or cannot support a prescription, and the store-and-forward definition covers only provider-to-provider images and videos. The Board for Professional Medical Conduct's statement on telemedicine could not be located online and was not read. [2] [3] [4] [5]
How does the New York pharmacy board treat compounding?
| Board | New York State Board of Pharmacy (State Education Department, Office of the Professions) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
In New York, the State Education Department registers pharmacies and licenses pharmacists under Education Law Article 137 (sections 6800 and following), with the State Board of Pharmacy advising on standards and discipline, and Commissioner's regulations in 8 NYCRR Part 63 set practice rules. Education Law section 6808-b requires every nonresident establishment (a pharmacy, manufacturer, wholesaler, or outsourcing facility outside New York, including internet pharmacies) that ships, mails, or delivers prescription drugs to New York patients to register with the Department, be licensed and in good standing in its home state, and keep retrievable records of drugs shipped into New York; 8 NYCRR 63.8 implements that requirement. On sterile compounding standards, 8 NYCRR Part 63 does not adopt USP chapters 795 or 797 by number. Instead, the Regents rule 8 NYCRR 29.2 makes it unprofessional conduct for a health professional to fail to adhere to applicable practice guidelines, as determined by the Commissioner, for compounding sterile drugs and products, and 8 NYCRR 63.7 requires pharmacists to complete at least three hours of compounding continuing education, consistent with current compounding standards, in each registration period beginning on or after January 1, 2023. New York has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [6] [7] [8] [9] [10]
Can you get compounded GLP-1s in New York?
A telehealth GLP-1 program shipping into New York must use a pharmacy registered as a nonresident establishment under Education Law section 6808-b, which patients can verify on the Office of the Professions license lookup. [6] [13]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in New York?
Access options
Prescriber licensed in New York, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in New York. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
CJC-1295 / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $220/month
Tesamorelin / Ipamorelin from Bodybuilding Peptides
SponsoredPartner lists from $274/month
Semax / Selank from Bodybuilding Peptides
SponsoredPartner lists from $274/month
We may earn a commission from these links.
Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.
Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.
Find a provider in New York
What you'll actually find in New York, and how to check
Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [17] [18] [19]
No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [20]
What New York has done
PeptideAgent has not found a board or legislative action on peptides in New York.
Other states have acted:
- On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [22] Mississippi law
- Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [23] [24] Louisiana law
Checking the prescriber
Telehealth prescribing of non-controlled peptides is permitted in New York. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. [2] [3] [4] [5] The telehealth rule in full.
Checking the pharmacy
Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the New York State Board of Pharmacy (State Education Department, Office of the Professions); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [21]
If you're going ahead anyway
These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [20]
They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [11] [25] [26]
Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [21] [27] [28]
What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [19] [28] [29]
Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [20] [30] [31] [32] [33] [34]
Check for:
- A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [20]
- A real evaluation by a licensed prescriber, not just an online form.
- A certificate of analysis for the specific batch.
Questions to ask
- Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [21]
- Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [19]
- Pharmacy: Is this made for me on a prescription written in my name? [29]
- Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [19] [28]
- Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [19]
What is offered for a specific peptide, and what FDA found, is on each peptide page.
Is it legal to buy research peptides in New York?
Education Law Article 137 limits dispensing of prescription drugs to registered pharmacies and licensed practitioners, and section 6808-b requires registration of any out-of-state establishment shipping prescription drugs into New York, including internet sellers. [6] [14]
Peptide-specific notes for New York
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including from a New York-licensed provider by telehealth. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [13] |
| Tirzepatide | Available branded by prescription. Compounded tirzepatide is limited to the federal patient specific exception since February 18, 2025, and an out-of-state pharmacy must be registered under Education Law section 6808-b to ship it into New York. [6] [13] |
Compare: Wegovy vs Zepbound.
Frequently asked questions
Can I get a GLP-1 prescription in New York through telehealth?
Yes, from a New York-licensed provider. Semaglutide and tirzepatide are not controlled substances. Public Health Law Article 29-G defines telehealth modes for service delivery and Medicaid reimbursement, not for prescribing, and New York law does not settle whether a prescription can be issued without a live visit. [2] [3] [4]
Does New York's store-and-forward telehealth cover online questionnaires?
Not by its terms. New York defines store-and-forward as the asynchronous transmission of patient-specific digital images or pre-recorded videos from one provider to another, and it says telehealth does not include electronic messaging alone. That law covers telehealth delivery and Medicaid reimbursement, not prescribing. New York law does not settle whether a prescription can be issued without a live visit or from a questionnaire alone. [3] [4]
Can an out-of-state pharmacy ship compounded peptides to me in New York?
Only if it is registered with the State Education Department as a nonresident establishment under Education Law section 6808-b. Check the Office of the Professions registration lookup before ordering. [6] [7]
Can a New York pharmacy compound BPC-157?
Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). State law still applies: New York has no state bulks list; peptide eligibility follows the federal 503A framework. [10] [11] [12] [15] [16]
From the blog
- Can you get a GLP-1 through telehealth in your state?
Yes in every state, but the rules for the visit, the prescriber's license, and the pharmacy differ. How state telehealth law shapes GLP-1 access, with state examples.
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.
- [1]New York State Education Department, Office of the Professions: Pharmacy
- [2]New York Public Health Law Article 29-G, Telehealth delivery of services
- [3]New York Public Health Law section 2999-cc, Telehealth definitions
- [4]New York Public Health Law section 2999-dd, Telehealth delivery of services
- [5]New York State Education Department, Office of the Professions: Telepractice Guidance
- [6]New York Education Law section 6808-b, Registration of nonresident establishments
- [7]8 NYCRR 63.8, Registration of nonresident establishments
- [8]8 NYCRR Part 63, Pharmacy (Regulations of the Commissioner of Education, including 63.7 continuing education)
- [9]8 NYCRR Part 29, Unprofessional conduct (section 29.2, general provisions for health professions)
- [10]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, October 28). Are peptides legal in New York?. https://peptideagent.ai/legal/new-york- HTML link
<a href="https://peptideagent.ai/legal/new-york">Are peptides legal in New York?</a>, PeptideAgent, updated October 28, 2026.